Scott Dahlbeck is Chief of Staff of Kiromic Biopharma, Inc.. Currently has a direct ownership of 496,757 shares of KRBP, which is worth approximately $541,465. The most recent transaction as insider was on Aug 11, 2022, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 497K
0% 3M change
0% 12M change
Total Value Held $541,465

Scott Dahlbeck Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2022
BUY
Grant, award, or other acquisition
-
50,000 Added 9.14%
496,757 Common Stock
May 23 2022
BUY
Exercise of conversion of derivative security
-
17,240 Added 3.72%
446,757 Common Stock
SD

Scott Dahlbeck

Chief of Staff
Houston, TX

Track Institutional and Insider Activities on KRBP

Follow Kiromic Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRBP shares.

Notify only if

Insider Trading

Get notified when an Kiromic Biopharma, Inc. insider buys or sells KRBP shares.

Notify only if

News

Receive news related to Kiromic Biopharma, Inc.

Track Activities on KRBP